Thursday, November 19, 2020 | 1:00pm EST
COST: $247 per dial-in connection
Sponsored by Lument
When the Patient Driven Payment Method (PDPM) for Medicare reimbursement went into effect a year ago, the consensus was that it would result in a jump in skilled nursing merger and acquisition activity as some providers would want out and others would see opportunity. That all changed in the beginning of 2020, when the coronavirus pandemic upended the universe and deaths in skilled nursing facilities surged while occupancy levels plunged.
Skilled nursing is not going away, and while it may change, most assisted living providers do not want to take on that level of acuity. And, for most nursing home residents, the same amount of care just can’t be provided in their homes at the same cost as in a nursing facility. Skilled nursing sales continued to close through all the months of the pandemic.
In this webcast, you will learn:
- Who is buying in today’s difficult times, and why
- How buyers are valuing a SNF when occupancy has declined and costs have increased
- Whether buyers are assuming permanently higher PPE and infection control costs
- If cap rates have risen as a result of the pandemic
- How the lending market for SNFs has reacted
- Who is selling SNFs right now and why
There is no doubt that the skilled nursing sector has been through a lot of pain since March, yet there are many providers who fared well and even kept COVID-19 out of their buildings. This winter may be a tough one, but that may also result in opportunity for the savvy investor. Join us as our panel of experts sorts out the issues and offers some answers.
Steve Monroe, Managing Editor, The SeniorCare Investor (moderator)
Laca Wong-Hammond, Managing Director, M&A, Lument
David Reis, Chief Executive Officer, Senior Care Development
Daniel J. Booth, Chief Operating Officer, Omega Healthcare Investors, Inc.
All webinars are live, but they are also recorded, allowing you to watch at a later date even if you are unable to attend the event live.